PRIME MOVERS LAB FUND I LP sold 2.6% of their position (96.94K shares) of VAXXINITY, INC. on the open market
Open‑market sale worth $168.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Class A Common Stock
Shares
−1.25K
Price / share
$1.88
Trade value
$2.35K
% of position
Class A Common Stock
Shares
−5.31K
Price / share
$1.88
Trade value
$9.99K
% of position
Class A Common Stock
Shares
−507.00
Price / share
$1.88
Trade value
$954.33
% of position
Class A Common Stock
Shares
−892.00
Price / share
$1.88
Trade value
$1.68K
% of position
Class A Common Stock
Shares
−2.19K
Price / share
$1.88
Trade value
$4.12K
% of position
Class A Common Stock
Shares
−4.79K
Price / share
$1.79
Trade value
$8.55K
% of position
Class A Common Stock
Shares
−20.31K
Price / share
$1.79
Trade value
$36.30K
% of position
Class A Common Stock
Shares
−1.94K
Price / share
$1.79
Trade value
$3.47K
% of position
Class A common stock
Shares
−3.41K
Price / share
$1.79
Trade value
$6.10K
% of position
Class A common stock
Shares
−8.38K
Price / share
$1.79
Trade value
$14.97K
% of position
Class A common stock
Shares
−5.91K
Price / share
$1.67
Trade value
$9.87K
% of position
Class A common stock
Shares
−25.09K
Price / share
$1.67
Trade value
$41.90K
% of position
Class A Common Stock
Shares
−2.40K
Price / share
$1.67
Trade value
$4K
% of position
Class A common stock
Shares
−4.22K
Price / share
$1.67
Trade value
$7.04K
% of position
Class A common stock
Shares
−10.35K
Price / share
$1.67
Trade value
$17.28K
% of position
Net shares
−96.94K
Net value
-$168.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 9/6/2023 | S · Sale | −1.25K | $1.88 | $2.35K | 0.1% | 2.07M | 2.06M |
| Class A Common Stock Direct | 9/6/2023 | S · Sale | −5.31K | $1.88 | $9.99K | 0.1% | 8.76M | 8.76M |
| Class A Common Stock Indirect | 9/6/2023 | S · Sale | −507.00 | $1.88 | $954.33 | 0.1% | 836.50K | 835.99K |
| Class A Common Stock Indirect | 9/6/2023 | S · Sale | −892.00 | $1.88 | $1.68K | 0.1% | 1.47M | 1.47M |
| Class A Common Stock Indirect | 9/6/2023 | S · Sale | −2.19K | $1.88 | $4.12K | 0.1% | 3.62M | 3.61M |
| Class A Common Stock Indirect | 9/7/2023 | S · Sale | −4.79K | $1.79 | $8.55K | 0.2% | 2.06M | 2.06M |
| Class A Common Stock Direct | 9/7/2023 | S · Sale | −20.31K | $1.79 | $36.30K | 0.2% | 8.76M | 8.74M |
| Class A Common Stock Indirect | 9/7/2023 | S · Sale | −1.94K | $1.79 | $3.47K | 0.2% | 835.99K | 834.05K |
| Class A common stock Indirect | 9/7/2023 | S · Sale | −3.41K | $1.79 | $6.10K | 0.2% | 1.47M | 1.47M |
| Class A common stock Indirect | 9/7/2023 | S · Sale | −8.38K | $1.79 | $14.97K | 0.2% | 3.61M | 3.60M |
| Class A common stock Indirect | 9/8/2023 | S · Sale | −5.91K | $1.67 | $9.87K | 0.3% | 2.06M | 2.05M |
| Class A common stock Direct | 9/8/2023 | S · Sale | −25.09K | $1.67 | $41.90K | 0.3% | 8.74M | 8.71M |
| Class A Common Stock Indirect | 9/8/2023 | S · Sale | −2.40K | $1.67 | $4K | 0.3% | 834.05K | 831.66K |
| Class A common stock Indirect | 9/8/2023 | S · Sale | −4.22K | $1.67 | $7.04K | 0.3% | 1.47M | 1.46M |
| Class A common stock Indirect | 9/8/2023 | S · Sale | −10.35K | $1.67 | $17.28K | 0.3% | 3.60M | 3.59M |
| Total | −96.94K | -$168.59K | ||||||